Transmedics Group Inc buy BiotechBee
Start price
29.04.24
/
70%
€88.94
Target price
31.05.26
€130.00
Performance (%)
-30.63%
End price
14.12.24
€61.70
Summary
This prediction ended on 14.12.24 with a price of €61.70. Massive losses of -30.63% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Transmedics Group Inc | 5.819% | 5.819% | -20.839% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
According to BiotechBee what are the pros and cons of Transmedics Group Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Transmedics Group Inc diskutieren
Buy mit Kursziel 130,0